Linden to Provide Oligo Probe Design Service to PamGene | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Linden Bioscience has signed a deal to provide its Tilia oligonucloetide probe design service to Dutch biotech firm PamGene International, the companies said today.

PamGene plans to use the probes with its 5D-Pulse microarray platform, which is the basis for the company's FD10 system and soon-to-be launched PamStation 96 microarray system.

Specific terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.